Jay T Flatley's Net Worth
$585 Million
Who is Jay T Flatley?
Jay T Flatley has an estimated net worth of $585 Million. This is based on reported shares across multiple companies, which include Rivian Automotive, Inc. / DE, COHERENT INC, Dynamics Special Purpose Corp., Denali Therapeutics Inc., Zymergen Inc., ILLUMINA INC, and Juno Therapeutics, Inc..
SEC CIK
Jay T Flatley's CIK is 0001189130
Past Insider Trading and Trends
2009 was Jay T Flatley's most active year for acquiring shares with 109 total transactions. Jay T Flatley's most active month to acquire stocks was the month of January. 2009 was Jay T Flatley's most active year for disposing of shares, totalling 235 transactions. Jay T Flatley's most active month to dispose stocks was the month of December. 2021 saw Jay T Flatley paying a total of $2,560,000.00 for 1,691,867 shares, this is the most they've acquired in one year. In 2015 Jay T Flatley cashed out on 1,351,280 shares for a total of $131,147,149.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Rivian Automotive, Inc. / DE (RIVN) Snapshot price: $13.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.22% | 24.22K |
—
|
—
| 144.01K |
Jun 18
| |||
Form 4
| +17.93% | 18.21K |
—
|
—
| 119.78K |
Jun 21
| |||
Form 4
| +9.67% | 8.96K |
—
|
—
| 101.58K |
Jun 6
| |||
Form 4
| +76.02% | 40K |
$29.31 | $1,172,400.00 | 92.62K |
May 26
| |||
Form 4
| +61.32% | 20K |
$78.00 | $1,560,000.00 | 52.62K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COHERENT INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -43.02K |
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 856 |
—
|
—
| 856 |
May 6
| |||
Form 4
|
∞
| 2.15K |
—
|
—
| 2.15K |
Apr 27
| |||
Form 4
| +149.87% | 24K |
$44.74 | $1,073,760.00 | 40.01K |
Mar 12
| |||
Form 4
|
∞
| 1.8K |
—
|
—
| 1.8K |
Feb 28
| |||
Form 4
|
∞
| 916 |
—
|
—
| 916 |
Mar 1
| |||
Form 4
| +10.78% | 1.29K |
—
|
—
| 13.29K |
Feb 15
| |||
Form 4
| -31.43% | -5.50K |
$305.80 | -$1,681,898.90 | 12K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| -10.26% | -2.00K |
$194.00 | -$388,000.00 | 17.5K |
Feb 17
| |||
Form 4
| +21.88% | 3.5K |
—
|
—
| 19.5K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +28.00% | 3.5K |
—
|
—
| 16K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +38.89% | 3.5K |
—
|
—
| 12.5K |
Feb 15
| |||
Form 4
| +28.57% | 2K |
—
|
—
| 9K |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +100.00% | 3.5K |
—
|
—
| 7K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
∞
| 3.5K |
—
|
—
| 3.5K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dynamics Special Purpose Corp. (SNTI) Snapshot price: $2.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Denali Therapeutics Inc. (DNLI) Snapshot price: $25.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +141.53% | 5.97K |
—
|
—
| 10.18K |
May 31
| |||
Form 4
| +1.25% | 4.22K |
—
|
—
| 340.53K |
Jun 1
| |||
Form 4
| +1.81% | 5.99K |
—
|
—
| 336.31K |
Jun 2
| |||
Form 4
| +0.63% | 2.07K |
—
|
—
| 330.33K |
Jun 2
| |||
Form 4
| +1.00% | 3.25K |
—
|
—
| 328.25K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 250K |
—
|
—
| 250K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zymergen Inc. No price found
Chairman and Acting CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -144.79K |
—
|
—
|
0
|
Oct 19
| |||
Form 4
| +223.27% | 100K |
$10.00 | $1,000,000.00 | 144.79K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
|
∞
| 44.79K |
—
|
—
| 44.79K |
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||